| Nodule risk assessment |
Scott Morris |
Maverix Medical |
NLST |
May 16, 2024 |
NLST-1252 |
| Underlying risk of developing and dying from lung cancer |
Louise Henderson |
University of North Carolina at Chapel Hill |
NLST |
May 16, 2024 |
NLST-1248 |
| Comparing Non-Malignancy Rate Definitions Utilizing the NLST Cohort |
Christopher Caruso |
University of Pennsylvania |
NLST |
May 16, 2024 |
NLST-1245 |
| Leveraging Machine Learning for Gynecologic Cancer Diagnosis: Visual Question Answering |
Elham Dolatabadi |
York University |
PLCO |
May 14, 2024 |
PLCOI-1557 |
| Validate Colon Cancer Model trained on synthetic data against PLCO dataset patient data |
Jeremy Howard |
Lucem Health, Inc. |
PLCO |
May 14, 2024 |
PLCO-1553 |
| Biomarker-assisted Decision Rule for Risk Classification under a positive predictive value - constraint: Application to disease screening |
Yingqi Zhao |
Fred Hutchinson Cancer Center |
PLCO |
May 14, 2024 |
PLCO-1556 |
| Heterogeneous treatment effect estimation using instrumental variable in time-to-event data |
Uri Shalit |
Technion - Israel Institute of Technology |
HIPB |
May 13, 2024 |
HIPB-13 |
| AI Modeling Project for Predicting Treatment Response in Non-Small Cell Lung Cancer |
Anna Gracia Colmenarejo |
Universidad Internacional de La Rioja |
PLCO |
Apr 29, 2024 |
PLCO-1542 |
| How effective is PSA Screening as a mode of prevention for Prostate Cancer in Men over the age of 50? |
Jiana Karthikeyan |
Franconian International School |
PLCO |
Apr 29, 2024 |
PLCO-1543 |
| A novel accuracy metric for general M-class classification when subclasses are involved |
Nan Nan |
State University of New York at Buffalo |
PLCO |
Apr 29, 2024 |
PLCO-1531 |
| Development and Validation of In-House Artificial Intelligence Models for Mutation and Survival Prediction |
Nikolaos Tsiknakis |
Karolinska Institutet |
PLCO |
Apr 29, 2024 |
PLCOI-1539 |
| Development of a Woman-Specific Risk Model for Participation in Lung Cancer CT Screening |
Marie-Pierre Revel |
APHP |
PLCO |
Apr 29, 2024 |
PLCO-1538 |
| 5DCT Radiation Oncology |
RICKY SAVJANI |
University of California Los Angeles |
NLST |
Apr 29, 2024 |
NLST-1240 |
| Development of a Woman-Specific Risk Model for Participation in Lung Cancer CT Screening |
Marie-Pierre Revel |
APHP |
NLST |
Apr 29, 2024 |
NLST-1237 |
| Prototype System for Supporting Urologists in Bladder Tumor Detection |
Jaime Hugo Puebla Lomas |
Instituto Politécnico Nacional |
PLCO |
Apr 18, 2024 |
PLCOI-1527 |
| Is Supervised machine learning algorithm comparative over nomograms in predicting biochemical recurrence after prostatectomy: a validation study |
Kheng Sit Lim |
AiM Medical Pte Ltd |
PLCO |
Apr 18, 2024 |
PLCO-1533 |
| Predicting cancer-specific mortality using histopathology slides |
Shu Jiang |
Washington University in St. Louis |
PLCO |
Apr 18, 2024 |
PLCOI-1532 |
| AI/ML based risk analysis for early cancer detection and prevention for high-risk, understudied, and/or underserved cancer populations. |
Amalendu Ranjan |
UNT Health Science Center |
PLCO |
Apr 18, 2024 |
PLCO-1529 |
| From clinical trials to real world practice: health status of community-dwelling veterans receiving lung cancer screening compared to randomized trial participants |
Alison Rustagi |
University of California, San Francisco |
NLST |
Apr 18, 2024 |
NLST-1236 |
| Evaluating the Cost-Effectiveness of the Sybil Model for Lung Nodule Surveillance in Cancer Screening |
Kei Chuen Ma |
Massachusetts Institute of Technology |
NLST |
Apr 18, 2024 |
NLST-1235 |
